Effect of risperidone on high-affinity state of dopamine D2 receptors: a PET study with agonist ligand [11C](R)-2-CH3O-N-n-propylnorapomorphine

The increased proportion of the high-affinity state of dopamine D2/3 receptors (D2,high) is assumed to correlate with dopamine hypersensitivity, implying a relationship with psychotic symptoms observed in psychiatric disorders such as schizophrenia. [11C](R)-2-CH3O-N-n-propylnorapomorphine ([11C]MNP...

Full description

Saved in:
Bibliographic Details
Published inThe international journal of neuropsychopharmacology Vol. 14; no. 1; pp. 83 - 89
Main Authors Kodaka, Fumitoshi, Ito, Hiroshi, Takano, Harumasa, Takahashi, Hidehiko, Arakawa, Ryosuke, Miyoshi, Michie, Okumura, Masaki, Otsuka, Tatsui, Nakayama, Kazuhiko, Halldin, Christer, Farde, Lars, Suhara, Tetsuya
Format Journal Article
LanguageEnglish
Published Cambridge, UK Cambridge University Press 01.02.2011
Oxford University Press
Subjects
Online AccessGet full text
ISSN1461-1457
1469-5111
DOI10.1017/S1461145710001148

Cover

Abstract The increased proportion of the high-affinity state of dopamine D2/3 receptors (D2,high) is assumed to correlate with dopamine hypersensitivity, implying a relationship with psychotic symptoms observed in psychiatric disorders such as schizophrenia. [11C](R)-2-CH3O-N-n-propylnorapomorphine ([11C]MNPA), which has an agonistic property to dopamine D2 receptors (D2Rs), is expected to bind preferentially to D2,high. The occupancy of dopamine D2Rs by antagonists to receptors has not been investigated using [11C]MNPA. We compared dopamine D2R occupancies by risperidone, an antagonist to receptors, between [11C]MNPA and [11C]raclopride to confirm whether risperidone occupies D2,high and D2,low at almost identical proportions. PET studies were performed on 11 healthy men under resting condition and following oral administration of a single dose of risperidone (0.5–2.0 mg). Striatal receptor occupancy for each radioligand was calculated. The relationship between dose or plasma concentration of risperidone and dopamine D2R occupancy was calculated. Striatal dopamine D2R occupancies measured with [11C]MNPA and [11C]raclopride were 22–65% and 24–69%, respectively. In the striatum, ED50 values measured with [11C]MNPA and [11C]raclopride were 0.98 and 1.03 mg, respectively. The striatal ED50 values as calculated from plasma concentration were 9.15 ng/ml and 8.01 ng/ml, respectively. Almost identical occupancies and ED50 values were observed between the two radioligands, indicating that risperidone bound to D2,high and D2,low at almost identical proportions in a dose-dependent manner.
AbstractList The increased proportion of the high-affinity state of dopamine D2/3 receptors (D2,high) is assumed to correlate with dopamine hypersensitivity, implying a relationship with psychotic symptoms observed in psychiatric disorders such as schizophrenia. [11C](R)-2-CH3O-N-n-propylnorapomorphine ([11C]MNPA), which has an agonistic property to dopamine D2 receptors (D2Rs), is expected to bind preferentially to D2,high. The occupancy of dopamine D2Rs by antagonists to receptors has not been investigated using [11C]MNPA. We compared dopamine D2R occupancies by risperidone, an antagonist to receptors, between [11C]MNPA and [11C]raclopride to confirm whether risperidone occupies D2,high and D2,low at almost identical proportions. PET studies were performed on 11 healthy men under resting condition and following oral administration of a single dose of risperidone (0.5–2.0 mg). Striatal receptor occupancy for each radioligand was calculated. The relationship between dose or plasma concentration of risperidone and dopamine D2R occupancy was calculated. Striatal dopamine D2R occupancies measured with [11C]MNPA and [11C]raclopride were 22–65% and 24–69%, respectively. In the striatum, ED50 values measured with [11C]MNPA and [11C]raclopride were 0.98 and 1.03 mg, respectively. The striatal ED50 values as calculated from plasma concentration were 9.15 ng/ml and 8.01 ng/ml, respectively. Almost identical occupancies and ED50 values were observed between the two radioligands, indicating that risperidone bound to D2,high and D2,low at almost identical proportions in a dose-dependent manner.
The increased proportion of the high-affinity state of dopamine D2/3 receptors (D2,high) is assumed to correlate with dopamine hypersensitivity, implying a relationship with psychotic symptoms observed in psychiatric disorders such as schizophrenia. [11C](R)-2-CH3O-N-n-propylnorapomorphine ([11C]MNPA), which has an agonistic property to dopamine D2 receptors (D2Rs), is expected to bind preferentially to D2,high. The occupancy of dopamine D2Rs by antagonists to receptors has not been investigated using [11C]MNPA. We compared dopamine D2R occupancies by risperidone, an antagonist to receptors, between [11C]MNPA and [11C]raclopride to confirm whether risperidone occupies D2,high and D2,low at almost identical proportions. PET studies were performed on 11 healthy men under resting condition and following oral administration of a single dose of risperidone (0.5a2.0 mg). Striatal receptor occupancy for each radioligand was calculated. The relationship between dose or plasma concentration of risperidone and dopamine D2R occupancy was calculated. Striatal dopamine D2R occupancies measured with [11C]MNPA and [11C]raclopride were 22a65% and 24a69%, respectively. In the striatum, ED50 values measured with [11C]MNPA and [11C]raclopride were 0.98 and 1.03 mg, respectively. The striatal ED50 values as calculated from plasma concentration were 9.15 ng/ml and 8.01 ng/ml, respectively. Almost identical occupancies and ED50 values were observed between the two radioligands, indicating that risperidone bound to D2,high and D2,low at almost identical proportions in a dose-dependent manner.
Abstract The increased proportion of the high-affinity state of dopamine D2/3 receptors (D2,high) is assumed to correlate with dopamine hypersensitivity, implying a relationship with psychotic symptoms observed in psychiatric disorders such as schizophrenia. [11C](R)-2-CH3O-N-n-propylnorapomorphine ([11C]MNPA), which has an agonistic property to dopamine D2 receptors (D2Rs), is expected to bind preferentially to D2,high. The occupancy of dopamine D2Rs by antagonists to receptors has not been investigated using [11C]MNPA. We compared dopamine D2R occupancies by risperidone, an antagonist to receptors, between [11C]MNPA and [11C]raclopride to confirm whether risperidone occupies D2,high and D2,low at almost identical proportions. PET studies were performed on 11 healthy men under resting condition and following oral administration of a single dose of risperidone (0.5-2.0 mg). Striatal receptor occupancy for each radioligand was calculated. The relationship between dose or plasma concentration of risperidone and dopamine D2R occupancy was calculated. Striatal dopamine D2R occupancies measured with [11C]MNPA and [11C]raclopride were 22-65% and 24-69%, respectively. In the striatum, ED50 values measured with [11C]MNPA and [11C]raclopride were 0.98 and 1.03 mg, respectively. The striatal ED50 values as calculated from plasma concentration were 9.15 ng/ml and 8.01 ng/ml, respectively. Almost identical occupancies and ED50 values were observed between the two radioligands, indicating that risperidone bound to D2,high and D2,low at almost identical proportions in a dose-dependent manner. [PUBLICATION ABSTRACT]
Author Arakawa, Ryosuke
Otsuka, Tatsui
Suhara, Tetsuya
Miyoshi, Michie
Takano, Harumasa
Okumura, Masaki
Halldin, Christer
Takahashi, Hidehiko
Ito, Hiroshi
Nakayama, Kazuhiko
Kodaka, Fumitoshi
Farde, Lars
Author_xml – sequence: 1
  givenname: Fumitoshi
  surname: Kodaka
  fullname: Kodaka, Fumitoshi
  organization: 1Clinical Neuroimaging Team, Molecular Neuroimaging Group, Molecular Imaging Center, National Institute of Radiological Sciences, Chiba, Japan
– sequence: 2
  givenname: Hiroshi
  surname: Ito
  fullname: Ito, Hiroshi
  email: hito@nirs.go.jp
  organization: 1Clinical Neuroimaging Team, Molecular Neuroimaging Group, Molecular Imaging Center, National Institute of Radiological Sciences, Chiba, Japan
– sequence: 3
  givenname: Harumasa
  surname: Takano
  fullname: Takano, Harumasa
  organization: 1Clinical Neuroimaging Team, Molecular Neuroimaging Group, Molecular Imaging Center, National Institute of Radiological Sciences, Chiba, Japan
– sequence: 4
  givenname: Hidehiko
  surname: Takahashi
  fullname: Takahashi, Hidehiko
  organization: 1Clinical Neuroimaging Team, Molecular Neuroimaging Group, Molecular Imaging Center, National Institute of Radiological Sciences, Chiba, Japan
– sequence: 5
  givenname: Ryosuke
  surname: Arakawa
  fullname: Arakawa, Ryosuke
  organization: 1Clinical Neuroimaging Team, Molecular Neuroimaging Group, Molecular Imaging Center, National Institute of Radiological Sciences, Chiba, Japan
– sequence: 6
  givenname: Michie
  surname: Miyoshi
  fullname: Miyoshi, Michie
  organization: 1Clinical Neuroimaging Team, Molecular Neuroimaging Group, Molecular Imaging Center, National Institute of Radiological Sciences, Chiba, Japan
– sequence: 7
  givenname: Masaki
  surname: Okumura
  fullname: Okumura, Masaki
  organization: 1Clinical Neuroimaging Team, Molecular Neuroimaging Group, Molecular Imaging Center, National Institute of Radiological Sciences, Chiba, Japan
– sequence: 8
  givenname: Tatsui
  surname: Otsuka
  fullname: Otsuka, Tatsui
  organization: 1Clinical Neuroimaging Team, Molecular Neuroimaging Group, Molecular Imaging Center, National Institute of Radiological Sciences, Chiba, Japan
– sequence: 9
  givenname: Kazuhiko
  surname: Nakayama
  fullname: Nakayama, Kazuhiko
  organization: 2Department of Psychiatry, Jikei University School of Medicine, Tokyo, Japan
– sequence: 10
  givenname: Christer
  surname: Halldin
  fullname: Halldin, Christer
  organization: 3Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden
– sequence: 11
  givenname: Lars
  surname: Farde
  fullname: Farde, Lars
  organization: 3Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden
– sequence: 12
  givenname: Tetsuya
  surname: Suhara
  fullname: Suhara, Tetsuya
  organization: 1Clinical Neuroimaging Team, Molecular Neuroimaging Group, Molecular Imaging Center, National Institute of Radiological Sciences, Chiba, Japan
BackLink https://www.ncbi.nlm.nih.gov/pubmed/20860881$$D View this record in MEDLINE/PubMed
BookMark eNqNkt-K1DAUxoOsuH_0AbyR4F6oYDQnbdLGOxlHV1hc0fVKpKRJOpOlTWrSIvMUvrIZZ1RYWfEqh5Pfd74TvhyjAx-8Reg-0GdAoXr-EUoBUPIKKKW5qG-ho9yShAPAwc8ayPb-EB2ndEUpK3kh7qBDRmtB6xqO0Pdl11k94dDh6NJoozPZAweP1261JqrrnHfTBqdJTXZLmTCqwWXkFcPRajtOIaYXWOH3y8tMzWaDv7lpjdUqeJcm3LuV8gZ_Blh8efzhCWFkcVZckHfEkzGGcdP7ENUYhhDHdR57F93uVJ_svf15gj69Xl4uzsj5xZu3i5fnRBeMAymUNrTtdGWBS2YN7wojZUmN5pRbKpXQrFW0lK0QgqnCUE41E4yZsmppbpygR7u5eYmvs01TM7ikbd8rb8OcGslLwSvJaSYfXiOvwhx9Xq6pgbOiLkuZodOboAKErLmk9ZZ6sKfmdrCmGaMbVNw0v-LIAOwAHUNK0Xa_EaDNNvLmr8izprqm0S6H5YKfonL9P5VPd8owj_9lVOyN1NDmf7Kyfx55s-oHGXfHwQ
CitedBy_id crossref_primary_10_1038_jcbfm_2011_201
crossref_primary_10_1002_med_21552
crossref_primary_10_1016_j_clinph_2019_12_405
crossref_primary_10_1016_j_psym_2020_05_013
crossref_primary_10_1016_j_pnpbp_2021_110246
crossref_primary_10_1038_s41386_020_0685_0
crossref_primary_10_1080_15622975_2024_2366235
crossref_primary_10_1097_FTD_0000000000001131
crossref_primary_10_1002_hbm_23844
crossref_primary_10_1007_s00406_023_01711_w
crossref_primary_10_1016_j_schres_2019_11_012
crossref_primary_10_1016_j_jaac_2011_10_019
ContentType Journal Article
Copyright CINP 2010
CINP 2010 2010
CINP 2010.
Copyright_xml – notice: CINP 2010
– notice: CINP 2010 2010
– notice: CINP 2010.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7X7
7XB
88E
88G
8AO
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
K9.
M0S
M1P
M2M
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
PSYQQ
Q9U
7TK
DOI 10.1017/S1461145710001148
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Psychology Database (Alumni)
ProQuest Pharma Collection
ProQuest Hospital Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
ProQuest One Community College
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
ProQuest Health & Medical Complete (Alumni)
Health & Medical Collection (Alumni)
Proquest Medical Database
Psychology Database
Proquest Central Premium
ProQuest One Academic (New)
ProQuest - Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest One Psychology
ProQuest Central Basic
Neurosciences Abstracts
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
ProQuest One Psychology
ProQuest Central Student
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Pharma Collection
ProQuest Central China
ProQuest Central
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Health & Medical Research Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest Central Basic
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Psychology Journals (Alumni)
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest Psychology Journals
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
Neurosciences Abstracts
DatabaseTitleList

Neurosciences Abstracts
Publicly Available Content Database
Publicly Available Content Database
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: http://www.proquest.com/pqcentral?accountid=15518
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
DocumentTitleAlternate F. Kodaka et al.
Effect of risperidone on dopamine D2 receptors
Thematic Section: New Developments in Schizophrenia Research
EISSN 1469-5111
EndPage 89
ExternalDocumentID 2201895541
20860881
10_1017_S1461145710001148
10.1017/S1461145710001148
Genre Clinical Trial
Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
-E.
.FH
0E1
0R~
0VX
123
29J
3V.
4.4
53G
5VS
74X
74Y
7X7
7~V
88E
8AO
8FI
8FJ
8R4
8R5
AAFWJ
AAMVS
AAOGV
AAPPN
AAPXW
AAVAP
ABITZ
ABIVO
ABKKG
ABMYL
ABPTD
ABQLI
ABUWG
ABXVV
ACGFS
ACIMK
ADBBV
ADHZD
ADRAZ
AEMTW
AENEX
AENZO
AFFVI
AFKRA
AFPKN
AFULF
AFUTZ
AHMBA
AJ7
ALMA_UNASSIGNED_HOLDINGS
ALUQC
AOIJS
ARABE
AVWKF
AZQEC
BAWUL
BAYMD
BCNDV
BENPR
BPHCQ
BTTYL
BVXVI
C0O
CAG
CCPQU
CIDKT
COF
CS3
DC4
DIK
DU5
DWQXO
EBS
EJD
EMOBN
FYUFA
GNUQQ
GROUPED_DOAJ
HG-
HMCUK
HST
HYE
HZ~
I.6
IAO
IHR
I~P
J36
J38
J3A
KQ8
KSI
L98
LW7
M-V
M1P
M2M
M48
ML0
M~E
O9-
OAWHX
OJQWA
OJZSN
OK1
P2P
PEELM
PQQKQ
PROAC
PSQYO
PSYQQ
Q2X
RHF
RIG
ROL
ROX
RPM
RR0
S6-
S70
TJX
TOX
TUQ
UKHRP
UU6
WQ3
WXU
WXY
WYP
ABEJV
ABGNP
ABVKB
ALIPV
AMNDL
H13
PIMPY
AAYXX
CITATION
ITC
PHGZM
PHGZT
CGR
CUY
CVF
ECM
EIF
NPM
PJZUB
PPXIY
7XB
8FK
K9.
PKEHL
PQEST
PQUKI
PRINS
Q9U
7TK
PUEGO
ID FETCH-LOGICAL-c3251-3acd0bfc7e1592ed5f3d9940dc505e09a6c2ba049b6662a3d050c2622d47b02a3
IEDL.DBID M48
ISSN 1461-1457
IngestDate Thu Sep 04 20:11:44 EDT 2025
Sat Jul 26 01:08:56 EDT 2025
Fri Jul 25 21:52:26 EDT 2025
Mon Jul 21 06:05:28 EDT 2025
Tue Jul 01 01:04:04 EDT 2025
Thu Apr 24 23:00:13 EDT 2025
Tue Feb 04 08:58:36 EST 2025
Wed Mar 13 05:46:35 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords receptor occupancy
Binding potential
[11C]MNPA
dopamine D2 receptor
risperidone
receptor
dopamine D
[
C]MNPA
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c3251-3acd0bfc7e1592ed5f3d9940dc505e09a6c2ba049b6662a3d050c2622d47b02a3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Article-2
ObjectType-Feature-1
content type line 23
OpenAccessLink https://www.proquest.com/docview/3169859089?pq-origsite=%requestingapplication%&accountid=15518
PMID 20860881
PQID 3169859089
PQPubID 43629
PageCount 7
ParticipantIDs proquest_miscellaneous_954657950
proquest_journals_815238449
proquest_journals_3169859089
pubmed_primary_20860881
crossref_primary_10_1017_S1461145710001148
crossref_citationtrail_10_1017_S1461145710001148
oup_primary_10_1017_S1461145710001148
cambridge_journals_10_1017_S1461145710001148
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 20110200
20110201
2011-2-00
2011-Feb
PublicationDateYYYYMMDD 2011-02-01
PublicationDate_xml – month: 02
  year: 2011
  text: 20110200
PublicationDecade 2010
PublicationPlace Cambridge, UK
PublicationPlace_xml – name: Cambridge, UK
– name: England
– name: Oxford
PublicationTitle The international journal of neuropsychopharmacology
PublicationTitleAlternate Int J Neuropsychopharmacol
PublicationYear 2011
Publisher Cambridge University Press
Oxford University Press
Publisher_xml – name: Cambridge University Press
– name: Oxford University Press
SSID ssj0024536
Score 1.9196906
Snippet The increased proportion of the high-affinity state of dopamine D2/3 receptors (D2,high) is assumed to correlate with dopamine hypersensitivity, implying a...
Abstract The increased proportion of the high-affinity state of dopamine D2/3 receptors (D2,high) is assumed to correlate with dopamine hypersensitivity,...
SourceID proquest
pubmed
crossref
oup
cambridge
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 83
SubjectTerms Adult
Apomorphine - analogs & derivatives
Apomorphine - metabolism
Brain - diagnostic imaging
Brain - drug effects
Brain - metabolism
Dopamine
Dopamine Agonists - metabolism
Dopamine Antagonists - blood
Dopamine Antagonists - metabolism
Dopamine Antagonists - pharmacology
Dopamine D2 Receptor Antagonists
Humans
Ligands
Magnetic Resonance Imaging
Male
Positron-Emission Tomography
Raclopride - metabolism
Radiopharmaceuticals - metabolism
Receptors, Dopamine D2 - agonists
Receptors, Dopamine D2 - metabolism
Risperidone - blood
Risperidone - metabolism
Risperidone - pharmacology
Schizophrenia - diagnostic imaging
Schizophrenia - metabolism
Young Adult
SummonAdditionalLinks – databaseName: ProQuest Central
  dbid: BENPR
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1baxNBFB5q--KLeDe2ynnQopLB2Z2dvQgiGlOCYAwlhYJImNuWQrq7mvYhv8K_7Dl7yVICwdeZ2ctwzpn55nK-j7FXmbA6Ucpyp5znkbWSp7nwXMswR7gdaGcoG_n7NJ6cRd_O1fkem3a5MHStshsT64HalZb2yN_LIM5SEujOPlW_OalG0elqJ6GhW2kF97GmGLvDDnBITtHvD76Mp7PTnn1PyTbfKOBBpJLunJNIpKmQyoIaJ5EgUM-2cGvWupUJtwVI64np5D671yJK-Ny4wAO254uH7HjWUFKvhzDvM6xWQziGWU9WvX7E_jb0xVDmgOFOtMeuLDyUBRCRMdd5folBv4Y68YhaOVxlXyE0ha8h4GjpK5Lr-QAaZuM51GS1QHu7oC9KIuWF5eWFLhz8DILRrzenb3nIRxP5g095wbFr1XpZoBNW5VWJBsfXPmZnJ-P5aMJbkQZuJdqSS22dMLlNPAKj0DuVS5dlkXAWsZUXmY5taDSuQwwulEItnVDChnEYuigxAguesP0CO_aMgcq9j41ziDE9tU91KoPcZSZKI2mEGbDhxiCLNtRWi-aaWrLYst-Aic5mC9sSnpPuxnLXI-82j1QN28euxq_REf6n3VHnKv1f9-48YIfb1SnCKplGEdbCphYDn05zdOHLm9UiIxn7JFNiwJ42_rf5lRDXqTh7BM93f_mQ3W12yOlyzhHbv_5z418gxLo2L9u4-QejjxxM
  priority: 102
  providerName: ProQuest
Title Effect of risperidone on high-affinity state of dopamine D2 receptors: a PET study with agonist ligand [11C](R)-2-CH3O-N-n-propylnorapomorphine
URI https://www.cambridge.org/core/product/identifier/S1461145710001148/type/journal_article
https://www.ncbi.nlm.nih.gov/pubmed/20860881
https://www.proquest.com/docview/3169859089
https://www.proquest.com/docview/815238449
https://www.proquest.com/docview/954657950
Volume 14
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1ZaxsxEBY5XvpSetdNavTQhrZYrVbHHoVSWtfBFOKa1AZDCYuuDQFn140T6P6K_uWO9rAbHEJeVyOh3ZlZfSNpvkHoVUKNiqQ0xErriDCGkzijjijOMoDbgbLaZyMfjcLhVHyfydkWastbNR9weWNo5-tJTS_m7__8Lj-Dw39qWII-_PS1qQMhPVFNhe-30S4sTKGPxY5EvKbek7xJNgqIF28POW8a4n-qhWtL1rU0uA00Wq1Khw_Q_QZO4i-1_h-iLZc_Qgfjmo-67OHJOr1q2cMHeLxmqi4fo781dzEuMgy-7jmPbZE7XOTYsxgTlWVn4PElrrKOvJSFEPsccCn-xjD8Kt3C1-r5iBUeDya4YqrFfmMXq9PCM_Li-dmpyi3-FQT9kzfHbwkj_SH_QUYkJ_Bqi3KegwUuivMCtA3DPkHTw8GkPyRNhQZiOCiScGUs1ZmJHKAi5qzMuE0SQa0BYOVookLDtIIgREOUxBS3VFLDQsasiDSFB0_RTg4v9hxhmTkXamsBYDovH6uYB5lNtIgF11R3UG-lkLQ1k7S-oxalG_rrINrqLDUN27kvujG_rcu7VZdFTfVxm_BrMIS7yO23prKeNQ_CJPbF5pMO2ttsjgFT8VgIaMWrVvB6f5SjcldcLdPE17CPEkk76Fltf6upMAhSYekIXtxxhnvoXr1P7q_o7KOdy4sr9xKA1qXuou1oFnXR7tfBaHzcrZzpH1TTG8c
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1baxQxFA51-6Av4t21VfNgi8oGM7nMRSii2y1b265L2UKhyJhJMqWwnVndFplf4T_yt3kylx3KwuJLX3OZSTiXfLmc7yD0JqJaBVJqYqSxRGjNSZhSSxRnKcBtT5nERSMfjfzhifh6Kk_X0N8mFsY9q2x8YumoTa7dGfkH7vlR6BJ0R59mP4nLGuVuV5sUGqpOrWB2SoqxOrDjwBa_YQs339nfBXlvMbY3mPSHpM4yQDSHwRCutKFJqgMLKzuzRqbcRJGgRgM4sDRSvmaJAiCdANJnihsqqWY-Y0YECYUC-O4dtC5chGsHrX8ZjMbHLduf5HV8k0c8IYPmXtWRVrtCV-aVuMwlIGrZHW6skjci75YAcLkQ7j1A92sEiz9XKvcQrdnsEdoeVxTYRQ9P2oiueQ9v43FLjl08Rn8qumScpxjci6NZNnlmcZ5hR5xMVJpegJMpcBno5FoZ2NVfAhTGuwyDd7Yzlx7oI1Z4PJjgkhwXu7NkrM5zRwKMpxfnKjP4zPP6398evyOM9If8GxmRjMDUZsU0A6Wf5Zc5KBh89gk6uRVxPUWdDCb2HGGZWusnxgCmta59qELupSZKRCh4QpMu6i0EEtemPY-rZ3FBvCS_LqKNzGJdE6y7PB_TVV3eL7rMKnaRVY23QBH-p91moyrtqFvz6aKN5eoQYBwPhYBavKgFR-Nuj1Rm8-t5HEnhyyCStIueVfq3GAqDfTGsVt6L1X9-je4OJ0eH8eH-6GAD3atO593DoE3Uufp1bV8CvLtKXtU2hNGP2zbbf7VcWJU
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Effect+of+risperidone+on+high-affinity+state+of+dopamine+D2+receptors%3A+a+PET+study+with+agonist+ligand+%5B11C%5D%28R%29-2-CH3O-N-n-propylnorapomorphine&rft.jtitle=The+international+journal+of+neuropsychopharmacology&rft.au=Kodaka%2C+Fumitoshi&rft.au=Ito%2C+Hiroshi&rft.au=Takano%2C+Harumasa&rft.au=Takahashi%2C+Hidehiko&rft.date=2011-02-01&rft.pub=Cambridge+University+Press&rft.issn=1461-1457&rft.eissn=1469-5111&rft.volume=14&rft.issue=1&rft.spage=83&rft.epage=89&rft_id=info:doi/10.1017%2FS1461145710001148&rft.externalDocID=10.1017%2FS1461145710001148
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1461-1457&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1461-1457&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1461-1457&client=summon